Skip to main content
. 2021 Mar 18;6(10):3343–3357. doi: 10.1016/j.bioactmat.2021.02.039

Fig. 1.

Fig. 1

The expression of SIRT3 in primary TJA and revision TJA tissues. (A) Images of clinical tissues collected from primary TJA and revision TJA. (B) Representative images of IHC staining of the expression of SIRT3. (C) Semiquantitative analysis of SIRT3-positive cells, at least 3 different areas were selected in each group for calculating the number of positive cells. (D-E) Protein levels of SIRT3 in primary TJA and revision TJA samples. (F) mRNA levels of SIRT3 in primary TJA and revision TJA samples. (n = 3 per group. Values are shown as the means ± s.d. **p < 0.01 and ***p < 0.005).